Bulletin
Investor Alert

AstraZeneca PLC ADR

NAS: AZN

GO
/marketstate/country/us

After Hours

AZN
/zigman2/quotes/200304487/composite

$

59.74

Change

-0.48 -0.80%

Volume

Volume 12,287

Oct 15, 2021, 6:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200304487/composite

Previous close

$ 59.67

$ 60.22

Change

+0.55 +0.92%

Day low

Day high

$60.08

$60.54

Open
Open: 60.27

52 week low

52 week high

$46.48

$61.34

Open

Market cap

$187.59B

Average volume

5.92M

P/E ratio

42.04

Rev. per Employee

$362,602

EPS

1.43

Dividend

0.45

Div yield

2.27%

Ex dividend date

8/12/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/azn

MarketWatch News on AZN

  1. Moderna Inc. stock underperforms Friday when compared to competitors

    4:31 p.m. Oct. 15, 2021

    - MarketWatch Automation

  2. Don't Count Out Covid-19 Monoclonal Antibody Treatments

    11:04 a.m. Oct. 15, 2021

    - Josh Nathan-Kazis

  3. Moderna Inc. stock outperforms competitors on strong trading day

    4:31 p.m. Oct. 14, 2021

    - MarketWatch Automation

  4. Moderna Inc. stock rises Wednesday, outperforms market

    4:31 p.m. Oct. 13, 2021

    - MarketWatch Automation

  5. Moderna Inc. stock outperforms competitors on strong trading day

    4:31 p.m. Oct. 12, 2021

    - MarketWatch Automation

  6. Another Covid Vaccine Inches Closer to the Market, Analyst Says

    10:37 a.m. Oct. 12, 2021

    - Josh Nathan-Kazis

  7. Moderna Inc. stock rises Monday, outperforms market

    4:31 p.m. Oct. 11, 2021

    - MarketWatch Automation

  8. Why the new SEC sheriff could be trouble for companies like Tesla

    7:18 a.m. Oct. 11, 2021

    - Barbara Kollmeyer

  9. Merck asks U.S. FDA to authorize promising anti-COVID pill

    6:23 a.m. Oct. 11, 2021

    - Associated Press

  10. Moderna Inc. stock underperforms Friday when compared to competitors

    4:31 p.m. Oct. 8, 2021

    - MarketWatch Automation

  11. Moderna Inc. stock outperforms competitors on strong trading day

    4:31 p.m. Oct. 7, 2021

    - MarketWatch Automation

  12. Moderna Inc. stock underperforms Wednesday when compared to competitors

    4:31 p.m. Oct. 6, 2021

    - MarketWatch Automation

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/azn

Other News on AZN

  1. Will AstraZeneca Have a Big Market for Its COVID-19 Therapy?

    8:01 a.m. Oct. 16, 2021

    - Motley Fool

  2. Moderna Vaccine for Adolescents Delayed for FDA Review

    4:28 p.m. Oct. 15, 2021

    - Felicia Schwartz

  3. U.S. to Lift Restrictions for International Travelers

    12:49 p.m. Oct. 15, 2021

    - Ken Thomas

  4. 2 Penny Stocks That Could Soar Soon

    10:00 a.m. Oct. 14, 2021

    - Motley Fool

  5. Here's Why Astrazeneca (AZN) is a Strong Momentum Stock

    10:00 a.m. Oct. 14, 2021

    - Zacks.com

  6. Loading more headlines...
/news/pressrelease/company/us/azn

Press Releases on AZN

  1. Cancer Immunotherapy Market Key Player SWOT Analysis and Forecast To 2025

    3:34 p.m. July 29, 2021

    - Market Insight Reports

  2. Vaccine Market Expectation Surges with Rising Demand and Changing Trends

    10:33 p.m. July 28, 2021

    - Market Insight Reports

  3. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/207505872/composite DISH+1.05%
  • /zigman2/quotes/204151124/composite CURE-1.23%
  • /zigman2/quotes/214908404/composite GFL+1.15%
  • /zigman2/quotes/204236046/composite DUST+1.32%
  • /zigman2/quotes/200683073/composite FRC+0.90%
X
Powered by StockTwits
Link to MarketWatch's Slice.